Building a Global Data Foundation for Scaling AI
How leading biopharm companies like Bayer are standardizing and integrating data for scaling impactful AI. AI use cases are rippling across commercial biopharma, helping companies…
AI Pharma
Making a Difference – The Business of Rare Disease Drug Development
Drug development designed to treat rare disease is both a noble cause and a risky business. Rare diseases are typically deadly, debilitating, and devastating for…
AI-Powered Precision Measures: A Golden Opportunity for Clinical Research
As the cost of developing new therapies continues to rise, pharma executives must turn to technologies that drive better insights into de-risked investments and produce…
How Connected Cloud-based Platforms are Advancing Quality in Biopharma Manufacturing
Robert Gaertner, Vice President of Quality Strategy Europe at Veeva Systems, discusses the growing importance of connected platforms in ensuring quality in pharmaceutical manufacturing and…
Regulatory AI Investment Essential Now, Survey Finds
Regulatory workloads now far exceed the pace of company growth, but assigning more people to the tasks isn’t an option, which in turn is driving…
Setting the Stage for AI in the Pharma Cold Chain
While AI in the pharma cold chain promises exciting possibilities, achieving these benefits is not a sprint but a marathon. The journey towards fully integrating…
Generative AI in Action in Life Sciences: Transforming Adverse Event Case Intake
Adverse event (AE) case intake in Life Sciences is crying out for disruption by AI. And now, at last, Generative AI and Large Language Models…
Could GenAI Revolutionise Pharma Medical Writing?
Medical writing in pharma is ripe for disruption, across use cases linked to regulatory documentation and safety report summaries, and Generative AI (GenAI) promises exactly…
What’s the State of AI-enabled Automation in Pharma R&D?
Smart automation promises to transform life sciences research and development operations, and streamline pharma companies’ path to market while enhancing patient safety. But how far…
2024 – Tech & Biotech Outlook
We’re in a new era of biotech, defined by the interplay between biology, data and AI. And it’s the enabling technologies — the connected instruments,…